Advisors Asset Management, Inc. Cerus Corp Transaction History

Advisors Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$4.5 - $7.02 $15,120 - $23,587	-3,360 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.87 - $5.49 $855 - $1,636	-298 Reduced 8.15%	3,360 $16,000
Q4 2019 Feb 14, 2020	SELL	$3.84 - $4.86 $1,274 - $1,613	-332 Reduced 8.32%	3,658 $15,000
Q3 2019 Nov 14, 2019	SELL	$4.86 - $6.05 $291 - $363	-60 Reduced 1.48%	3,990 $21,000
Q2 2019 Aug 14, 2019	BUY	$4.51 - $6.6 $5,511 - $8,065	1,222 Added 43.21%	4,050 $23,000
Q1 2019 May 15, 2019	BUY	$5.16 - $6.85 $14,592 - $19,371	2,828 New	2,828 $18,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.